Discussion: Patient Participation in HTA—Evidence of Real Change?-Reference-Cited by-同舟云学术

Discussion: Patient Participation in HTA—Evidence of Real Change?

Published:2017 Issue: Volume: Page:373-380
ISSN:
Container-title:Patient Involvement in Health Technology Assessment
language:
Short-container-title:

Author:

Wong-Rieger Durhane

Publisher

Springer Singapore

Link

http://link.springer.com/content/pdf/10.1007/978-981-10-4068-9_32

Reference10 articles.

1. ADAPTSMART. Accelerated development of appropriate patient therapies. 2016. http://adaptsmart.eu/the-european-medicines-agency-on-adaptive-pathways/ . Accessed 20 Oct 2016.

2. Australian Government Department of Health. Life saving drugs program criteria and conditions. 2016. http://www.health.gov.au/internet/main/publishing.nsf/Content/lsdp-criteria . Accessed 20 Oct 2016.

3. Hoos A, Anderson J, Boutin M, Dewulf L, Geissler J, et al. Partnering with patients in the development and lifecycle of medicines: a call for action. Ther Innov Regul Sci. 2015;49:929–9.

4. Lewis JRR, Kerridge I, Lipworth W. Coverage with evidence development and managed entry in the funding of personalized medicine: practical and ethical challenges for oncology. J Clin Oncol. 2015;33:4112–7.

5. NICE. NICE highly specialised technologies guidance. 2016. https://www.nice.org.uk/about/what-we-do/our-programmes/nice-guidance/nice-highly-specialised-technologies-guidance . Accessed 20 Oct 2016.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an international template to support patient submissions in Health Technology Assessments;International Journal of Technology Assessment in Health Care;2021

2. Role of patients’ organizations in Health Technology Assessment: a Habermasian system and lifeworld perspective;International Journal of Technology Assessment in Health Care;2020-12-15